PTHS · Insider trading · 13F holders · Congress trades
Pelthos Therapeutics Inc. (PTHS)
Who is buying and selling PTHS: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 4
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $45K
- Congress trades, 12 months
- 0
PTHS at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 PTHS insiders filed 3 sales worth $45K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
- 4 13F filers hold PTHS among their 50 largest positions, worth $25.8M combined. The biggest bets by portfolio weight are Murchinson Ltd. (4.2%), Ikarian Capital, LLC (1.2%) and AIGH Capital Management LLC (0.8%). In their latest 13Fs, 1 manager opened a new position and 0 added to one.
- No member of Congress has disclosed a trade in PTHS.
- PTHS last closed at $16.54 on Oct 29, 2026.
PTHS insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 PTHS insiders filed 3 sales worth $45K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Greenleaf Peter | Director | Sale10b5-1 | 797 | $21.17 | $17K | SEC |
| Oct 6, 2026 | Pauls Matthew | Director | Sale10b5-1 | 786 | $21.00 | $17K | SEC |
| Oct 6, 2026 | Friedberg Ezra M | Director | Sale10b5-1 | 558 | $20.72 | $12K | SEC |
Who owns PTHS? Hedge funds and superinvestors
4 13F filers hold PTHS among their 50 largest positions, worth $25.8M combined. The biggest bets by portfolio weight are Murchinson Ltd. (4.2%), Ikarian Capital, LLC (1.2%) and AIGH Capital Management LLC (0.8%). In their latest 13Fs, 1 manager opened a new position and 0 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| AIGH Capital Management LLCHedge fund | 0.8% | $9.3M | 329,098 | New | Q2 2026 |
| Murchinson Ltd.Hedge fund | 4.2% | $8.6M | 304,302 | +2.7% shares | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 1.2% | $7.3M | 256,598 | +0.0% shares | Q2 2026 |
| Knott David M JrInvestment manager | 0.3% | $624K | 22,073 | +4.7% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 4). Screen PTHS in the grand portfolio →
PTHS stock trades by members of Congress
No member of Congress has disclosed a trade in PTHS.
PTHS questions and answers
Are insiders buying PTHS stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 PTHS insiders filed 3 sales worth $45K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own PTHS?
4 13F filers hold PTHS among their 50 largest positions, worth $25.8M combined. The biggest bets by portfolio weight are Murchinson Ltd. (4.2%), Ikarian Capital, LLC (1.2%) and AIGH Capital Management LLC (0.8%). In their latest 13Fs, 1 manager opened a new position and 0 added to one.
Has Congress traded PTHS?
No member of Congress has disclosed a trade in PTHS.
Who is the largest holder of PTHS?
Among 13F filers, AIGH Capital Management LLC reports the largest PTHS position, $9.3M (329,098 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Murchinson Ltd.'s: 4.2% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.